Managing Placenta Accreta Spectrum with Prophylactic Uterine Artery Embolization: A Case Report

Download Article

DOI: 10.21522/TIJPH.2013.13.02.Art008

Authors : Periasamy Anbu, A. Emaya, A. Parimala

Abstract:

The Placenta accreta spectrum (PAS) encompasses several conditions including placenta accreta, increta, and percreta. These conditions are characterized by abnormal placental attachment and invasive growth into the uterine wall, often resulting from defects in the endometrial–myometrial interface and inadequate decidualization at sites of previous uterine scars. This case report highlights the importance of early and proactive intervention with vessel embolization in managing PAS. A 26-year-old female with a history of lower segment cesarean section (LSCS) was diagnosed with placenta accreta. A multidisciplinary approach was employed to manage her condition. The patient underwent an elective cesarean section combined with bilateral internal iliac artery embolization. The removal of an invasive placenta is associated with a high risk of massive blood loss during the peripartum period. Prophylactic intraoperative uterine artery embolization (UAE) significantly mitigated this risk by reducing blood loss associated with the removal of the invasive placenta. For patients with placenta accreta who wish to preserve their fertility, UAE is considered a safer and more effective option. The use of UAE as a preventive measure before or during delivery helps manage bleeding complications and supports better outcomes in the management of PAS.

References:

[1]. Ogunleye, O. O., Anand, A., Khatib, M.N., Ajayi, A. O., Zahiruddin, Q. S., Rustagi, S., Satapathy, P., Woldehana, N.A., 2024, Endovascular treatment versus standard medical treatment in patients with established large infarct: A cohort study. Int J Surg, 110, 4775-4784.

[2]. Obstetric care consensus, 2018, Placenta accreta spectrum. Obstetrics Gynecol, 132, e259. 

[3]. Chandrasekhar, P., Rangasami, R., Andrew, C., Paarthipan, N., 2023, Placental perfusion imaging on 3Tesla magnetic resonance imaging using pseudo-continuous arterial spin labelling: an initial experience. Egypt J Radiol Nucl Med, 54, 170.

[4]. Usta, I. M., Hobeika, E. M., Musa, A. A., Gabriel, G. E., Nassar, A. H., 2005, Placenta previa-accreta: risk factors and complications. Am J Obstet Gynecol, 193, 1045–1049.

[5]. Bowman, Z. S., Eller, A. G., Bardsley, T. R., Greene, T., Varner, M. W., Silver, R. M., 2014, Risk factors for placenta accreta: a large prospective cohort. Am J Perinatol, 31, 799–804.

[6]. Vishnuvanditha, V., Selvankumar, T., 2024. Anaesthetic management of a patient with Placenta Previa (PP) - A case study. Texila Int J Public Health.

[7]. Bowman, Z. S., Eller, A. G., Kennedy, A. M., Richards, D. S., Winter, T. C., Woodward, P. J., et al., 2014, Interobserver variability of sonography for prediction of placenta accreta. J Ultrasound Med, 33, 2153–2158.

[8]. Collins, S. L., Ashcroft, A., Braun, T., Calda, P., Langhoff-Roos, J., Morel, O., et al., 2016, Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). European Working Group on Abnormally Invasive Placenta, (EW-AIP). Ultrasound Obstet Gynecol, 47, 271–275.

[9]. Use of prophylactic antibiotics in labor and delivery, 2011, Practice Bulletin No. 120. American College of Obstetricians and Gynecologists. Obstet Gynecol, 117, 1472–1483.

[10]. Cravello, L., Petrakian, M., Roger, V., 2008, Placenta accreta: etiologies. Realites en Gynecologie-Obstetrique, 129, 24.

[11]. Clouqueur, E., Rubod, C., Paquin, A., Devisme, L., Deruelle, P., 2008, Placenta accreta: diagnosis and management in a French type-3 maternity hospital. J Gynecol Obstet Biol Reprod (Paris), 37, 499–504.

[12]. Abdoulaye, N., Pascal, C., Armelle, B., Jean M. C., et al., 2010, Placenta Accreta: Management with Uterine Artery Embolization in 17 Cases. J Vasc Interv Radiol, 21, 644–648. 

[13]. Silver, R. M., Landon, M. B., Rouse, D. J., et al., 2006, Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol, 107, 1226 – 1232.

[14]. La Folie, T., Vidal, V., Mehanna, M., et al., 2007, Results of endovascular treatment in cases of abnormal placentation with post-partum hemorrhage. J Obstet Gynaecol Res, 33, 624–630.

[15]. Twickler, D. M., Lucas, M. J., Balis, A. B., et al., 2000, Color flow mapping for myometrial invasion in women with a prior caesarean delivery. J Matern Fetal Med, 9, 330–335.